Angle

Medical diagnostics company with products in the cancer diagnostics and fetal health markets.

Launch date

Jan 1994

Employees

Market cap

Enterprise valuation

€30m (Public information from Sep 2024)

Company register number 10087031

Guildford England (HQ)

http://angleplc.com

https://twitter.com/parsortix https://www.linkedin.com/company/angle-technology

View job openings

Revenues, earnings & profits over time

GBP	2020	2021	2022	2023	2024	2025	2026
Revenues	<1m	1.0m	1.0m	2.2m	8.3m	17.2m	36.1m
% growth	-	33 %	3 %	110 %	277 %	108 %	110 %
EBITDA	(12.2m)	(15.7m)	(21.2m)	(18.9m)	(14.8m)	(12.5m)	(3.1m)
% EBITDA margin	(1606 %)	(1552 %)	(2040 %)	(865 %)	(179 %)	(73 %)	(9 %)
Profit	(11.6m)	(15.0m)	(21.7m)	(20.1m)	(15.8m)	(13.8m)	(5.8m)
% profit margin	(1523 %)	(1482 %)	(2083 %)	(921 %)	(192 %)	(81 %)	(16 %)
EV / revenue	97.3x	244.6x	95.7x	6.6x	5.3x	2.5x	1.2x
EV / EBITDA	-6.1x	-15.8x	-4.7x	-0.8x	-3.0x	-3.4x	-14.1x
R&D budget	3.7m	3.4m	4.5m	2.5m	-	-	-
R&D % of revenue	480 %	340 %	431 %	113 %	-	-	-

Date	Investors	Amount	Round
Mar 2015	N/A	$250k	Early VC
Nov 2016	N/A	N/A	IPO
Oct 2020	N/A	£20.0m	Post IPO Equity
Jul 2022*	N/A	£20.1m	Post IPO Equity
Jun 2024*	N/A	£500k	Post IPO Equity
Total Funding		€227k

Tech stackLearn more about the technologies and tools that this company uses.

MyVox Ultrasonics